Login to Your Account

Asmacure Seeks Better Fix for Asthma, COPD

By Marie Powers
Staff Writer

Wednesday, July 31, 2013
When it comes to treating pulmonary disease, Asmacure Ltée is seeking to build a better mousetrap. The Quebec City-based biotech was founded in 2002 by pulmonologist Yvon Cormier, the company's chief medical officer, who was exploring the role of nicotinic targets in inflammatory and pulmonary diseases.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription